Savara SVRA
NASDAQ SVRA
$5.36 -0.01 (-0.09%)
As of: Sep 4, 2026 · 2:25 PM EDT

Savara (SVRA) EPS (Basic) (2010 - 2026)

Savara (SVRA) posted quarterly EPS (Basic) of -$0.15 for Q1 2026, down 19.44% year-over-year from -$0.18 in Q1 2025, and down 1.55% quarter-over-quarter from -$0.14 in Q4 2025.

Analysis

Savara (SVRA) EPS (Basic) (2010 - 2026) Analysis & Trends

Savara (SVRA) has reported EPS (Basic) for 17 consecutive years, with -$0.15 the latest figure, recorded in Q1 2026.

  • In Q1 2026, EPS (Basic) fell 19.44% year-over-year to -$0.15; the TTM figure through Mar 2026 stood at -$0.51 (down 8.15% YoY), while the FY2025 annual figure was -$0.53, down 10.46% from the prior year.
  • EPS (Basic) declined to -$0.15 in Q1 2026 per SVRA's latest filing, from -$0.14 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.05 in Q1 2022 and bottomed at -$0.15 in Q1 2026.
  • Historically, EPS (Basic) has averaged -$0.1 across 5 years, with a median of -$0.11 in 2024.
  • Annual changes were most pronounced in 2022 — EPS (Basic) surged 59.06% — and 2024, when it slumped 62.67%.
  • Savara's EPS (Basic) stood at -$0.07 in 2022, then slumped by 44.54% to -$0.1 in 2023, then sank by 50.38% to -$0.15 in 2024, then rose by 1.09% to -$0.14 in 2025, then fell by 1.55% to -$0.15 in 2026.
  • Business Quant data shows SVRA's EPS (Basic) at -$0.15 in Q1 2026, -$0.14 in Q4 2025, and -$0.14 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn 12.62
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 7.70
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.04 Bn 44.04 Bn - -3.06
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn 2.12
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 1.23
8 Royalty Pharma 28.41 Bn 27.57 Bn - 0.18
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn -0.06
10 Savara 1.36 Bn 1.36 Bn - -0.16
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.16
Mar 31, 2026 -0.15
Dec 31, 2025 -0.14
Sep 30, 2025 -0.14
Jun 30, 2025 -0.14
Mar 31, 2025 -0.12
Dec 31, 2024 -0.15
Sep 30, 2024 -0.11
Jun 30, 2024 -0.12
Mar 31, 2024 -0.11
Dec 31, 2023 -0.10
Sep 30, 2023 -0.10
Jun 30, 2023 -0.07
Mar 31, 2023 -0.07
Dec 31, 2022 -0.07
Sep 30, 2022 -0.07
Jun 30, 2022 -0.06
Mar 31, 2022 -0.05
Dec 31, 2021 -0.08
Sep 30, 2021 -0.07